Trial Profile
A Phase I Vaccine Study With Autologous Dendritic Cells Loaded With Oncofetal Antigen/iLRP in Patients With Metastatic Breast Cancer.
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs OFA cancer vaccine-Quantum Immunologics (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions
- 23 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Aug 2009 Trial phase changed from I/II to I as reported by ClinicalTrials.gov.